Create
Log in
Enquire now
Kernal Biologics
Cambridge, MA-based company developing targeted mRNA therapeutics for cancer and other diseases.
Overview
Structured Data
Issues
Contributors
Access by API
Access by API
Is a
Company
Organization
Accelerator
Y Combinator
B2X
B2C
CEO
Yusuf Erkul
0
CIK Number
1,684,728
Company Operating Status
Active
Competitors
Akcea Therapeutics
Ionis Pharmaceuticals
Alnylam Pharmaceuticals
Moderna Therapeutics
CureVac
Arrowhead Pharmaceuticals
BioNTech
Country
United States
Crunchbase URL
crunchbase.com/organiz...iologics
Email Address
kernalbio@gmail.com
hello@kernalbio.com
Facebook URL
@KernalBiologics-1770335909881227
Founded Date
2016
Founder
Yusuf Erkul
0
Cafer Ozdemir
0
Burak Yilmaz
0
Full Address
700 Main Street, North Cambridge, MA, 02139, United States
Accelerator Batch
Y Combinator S20 Batch
Industry
Drug delivery
Internal medicine
Vaccine
Pharmaceutical industry
Engineering
Oncology
Healthcare
Therapeutics
Biotechnology
Biology
•••
Investors
MassChallenge
0
Y Combinator
Hummingbird Ventures
Amgen Ventures
Civilization Ventures
0
Luminous Ventures
Latest Funding Round Date
July 7, 2022
Latest Funding Round Amount (USD)
25,000,000
Latest Funding Type
Series A
LinkedIn URL
@company/kernal-biologics-inc.
Location
United States
North Cambridge, Massachusetts
Cambridge, Massachusetts
Number of Employees
4
Number of Employees (Ranges)
1 – 10
Phone Number
+18576000762
Pitchbook URL
pitchbook.com/profiles...166787-65
Total Funding Amount (USD)
50,596,668
Twitter URL
@kernalbio
Official Website
kernalbio.com
Find more companies like Kernal Biologics
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE